This week was heavy in the clinic and OR. We started out with attending the weekly multidisciplinary tumor board on Monday. Doctors discussed treatment plans for several patients. Doctors from surgical oncology, medical oncology and radiation oncology discussed treatment plans for several cases, depending on the grade of tumor, previous tumor and treatment history etc. It was very interesting to see oncologists specializing in different fields discuss and customize treatment plans for each patient individually.
Tuesday, I was fortunate to shadow Dr. Newman in clinic. Dr. Newman saw 7 patients. Most of them were either follow-up consultations who had surgeries in the last few weeks or newly diagnosed breast cancer patients who came in to discuss their treatment plans with Dr. Newman. It was amazing how Dr. Newman patiently discussed treatment options and plans with each patient and answered all of their questions. On Wednesday and Thursday, I shadowed Dr. Newman in the OR. She performed several surgeries ranging from bilateral mastectomies, radioactive seed localized lumpectomies to sentinel lymph node biopsies (to test for invasiveness of the cancer). One of these surgeries was particularly interesting, a wire guided lumpectomy instead of a radioactive seed to track the location of the tumor and calcifications. On Friday, Dr. Newman conducted a didactic session wherein she discussed Ductal Carcinoma In Situ (DCIS) and the COMET (Comparing an Operation to Monitoring, With or Without Endocrine Therapy) clinical trial for DCIS. In the lab, we had to redo a few steps for the TCR library preparation as the QC report from last week's TCR library was not great. We have submitted the new sample to the genomics core facility and will go ahead with the sequencing if the QC results come back positive!
No comments:
Post a Comment